Lacosamide 31722-0627-46
- Manufacturer
- Camber Pharmaceuticals, Inc.
- Dosage Form
- Solution
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- May 31, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA209301
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 10 mg/mL |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
31722-0627-46Selected1 BOTTLE in 1 CARTON (31722-627-46) / 465 mL in 1 BOTTLE
Other packages for this product(1)
1 BOTTLE in 1 CARTON (31722-627-26) / 200 mL in 1 BOTTLE